p53 immunoexpression in carcinomas arising in pleomorphic adenoma

International Journal of Surgical Pathology

Volumn 3, Issue 4, 1996, Pages 257-262

  Rosa, Joaninha Costa ^a   Fonseca, Isabel ^a   Félix, Ana ^a   Soares, Jorge ^a  

^a INSTITUTO PORTUGUÊS DE ONCOLOGIA DE LISBOA FRANCISCO GENTIL   (Portugal)

Author keywords

Carcinoma expleomorphic adenoma; Immunohistochemistry; p53; Pleomorphic adenoma; Salivary glands

Indexed keywords

PROTEIN P53;

ADENOCARCINOMA; ADENOSQUAMOUS CARCINOMA; ADULT; AGED; ANAPLASTIC CARCINOMA; ARTICLE; CLINICAL ARTICLE; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MYOEPITHELIOMA; ONCOCYTOMA; PLEOMORPHIC ADENOMA; PRIORITY JOURNAL; SALIVARY GLAND CARCINOMA;

EID: 0029938323     PISSN: 10668969     EISSN: None     Source Type: Journal    
DOI: 10.1177/106689699604030405     Document Type: Article

References (14)

1. Soussi T, Legros Y, Lubin R, Ory K, Schlichtholz B. Multifactorial analysis of p53 alteration in human cancer: A review. Int J Cancer 57:1-9, 1994
2. Finlay CA, Hinds PW, Tan TH, Eliyahu D, Oren M, Levine AJ. Activating mutations for transformation by p53 produce a gene product that forms an hsc700-p53 complex with an altered half-life. Mol Cell Biol 8:531-539, 1988
3. Baas IO, Mulder J-WR, Offerhaus JA, Vogelstein B, Hamilton SR. An evaluation of six antibodies for immunohistochemistry of mutant p53 gene product in archival colorectal neoplasms. J Pathol 172:5-12, 1994
4. Gnepp DR. Malignant mixed tumors of salivary glands: A review. Pathol Ann 28:279-328, 1993
5. Seifert G. Histopathology of malignant salivary gland tumours. Oral Oncol Eur J Cancer 28B:49-56, 1992
6. Soini Y, Kamel D, Nurova K, Lane DP, Vahakangas K, Paakko P. Low p53 protein expression in salivary gland tumors compared to lung carcinomas. Virchows Arch A Pathol Anat 421:415-420, 1992
7. Deguchi H, Hamano H, Hayashi Y. c-myc, ras p21 and p53 expression in pleomorphic adenoma and its malignant form of the human salivary glands. Acta Pathol Jpn 43:413-422, 1993
8. Ishi K, Nakajima T. Evaluation of malignant grade of salivary gland tumors: Studies by cytofluorometric nuclear DNA analysis, histochemistry for nucleolar organizer regions and immunohistochemistry for p53. Pathol Int 44:287-296, 1994
9. Seifert G, Brocheriou C, Cardesa A, Eveson JW. WHO international-histological classification of tumors. Pathol Res Pract 186:555-581, 1990
10. Hellquist HB, Karlsson MG, Nilsson C. Salivary duct carcinoma: A highly aggressive salivary gland tumour with overexpression of c-erbB-2. J Pathol 172:35-44, 1994
11. Batsakis JG, El-Naggar AK. p53: Fifteen years after discovery. Adv Anat Pathol 2:71-88, 1995
12. Thor AD, Yandell DW. Prognostic significance of p53 overexpression in node-negative breast carcinoma: Preliminary studies support cautious optimism. J Natl Cancer Inst 85:176-177, 1993
13. Hurlimann I, Chaubert P, Benhattar J. p53 gene alterations and p53 protein accumulation in infiltrating ductal breast carcinomas: Correlation between immunohistochemical and molecular biology techniques. Mod Pathol 7:423-428, 1994
14. Fearon ER, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell 61:759-767, 1990